Delic Holdings Corp. (DELCF)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Delic Holdings Corp. (DELCF) with AI Score 57/100 (Hold). Delic Holdings Corp. operates in the burgeoning psychedelic wellness sector, providing media platforms, educational resources, and ketamine infusion treatments. Market cap: 0, Sector: Communication services.
Last analyzed: Mar 16, 2026Delic Holdings Corp. (DELCF) Media & Communications Profile
Delic Holdings Corp. is a diversified company in the psychedelic wellness space, offering media platforms like Reality Sandwich and Meet Delic events, alongside ketamine infusion clinics. The company focuses on creating content and providing treatments within the emerging psychedelic medicine market, primarily in the United States and Canada.
Investment Thesis
Delic Holdings Corp. presents a unique investment opportunity within the nascent psychedelic wellness sector. The company's diversified approach, encompassing media, education, and clinical treatments, positions it to capitalize on the growing interest in psychedelic therapies. Key value drivers include the expansion of its ketamine infusion clinic network and the growth of its online education platform, Reality Sandwich. The company's gross margin is 100.0%. Potential catalysts include favorable regulatory changes regarding psychedelic therapies and increasing public acceptance of these treatments. However, investors should be aware of the risks associated with operating in a highly regulated and evolving industry, as well as the company's negative profit margin of -565.9%.
Based on FMP financials and quantitative analysis
Key Highlights
- Delic Holdings Corp. operates in the emerging psychedelic wellness market, focusing on media, education, and clinical treatments.
- The company's media platforms, including Reality Sandwich and Meet Delic, aim to foster public discourse and education around psychedelics.
- Delic owns and operates ketamine infusion clinics, providing therapeutic treatments in the United States and Canada.
- The company's gross margin is 100.0%, indicating strong potential for profitability as the market matures.
- Delic's market capitalization is $0.00B, reflecting its early-stage growth and potential for future expansion.
Competitors & Peers
Strengths
- Diversified business model encompassing media, education, and clinical treatments.
- Established media platforms with a significant online presence.
- Ownership of ketamine infusion clinics provides a direct revenue stream.
- Focus on research and development for cannabis and psychedelics.
Weaknesses
- Negative profit margin indicates financial challenges.
- Small market capitalization and limited trading volume on the OTC market.
- Reliance on a nascent and evolving regulatory environment.
- Limited brand recognition compared to larger players in the wellness industry.
Catalysts
- Ongoing: Increasing public awareness and acceptance of psychedelic therapies.
- Upcoming: Potential regulatory changes regarding the use of psychedelics for mental health treatment.
- Ongoing: Expansion of ketamine infusion clinic network across North America.
- Ongoing: Growth of online education platform through content expansion and marketing efforts.
Risks
- Potential: Unfavorable regulatory changes regarding psychedelic therapies.
- Ongoing: Increased competition from larger and more established players in the wellness industry.
- Potential: Negative public perception or safety concerns regarding psychedelics.
- Ongoing: Economic downturn impacting consumer spending on wellness services.
- Ongoing: Negative profit margin indicates financial challenges.
Growth Opportunities
- Expansion of Ketamine Infusion Clinics: Delic has the opportunity to expand its network of ketamine infusion clinics across North America. The market for ketamine treatments is growing, driven by its effectiveness in treating depression and other mental health conditions. By strategically opening new clinics in underserved areas, Delic can increase its revenue and market share. The timeline for expansion is ongoing, with potential for significant growth over the next 3-5 years. This expansion can establish Delic as a leading provider of psychedelic-assisted therapies.
- Growth of Online Education Platform: Reality Sandwich, Delic's online education platform, has the potential to become a leading resource for information on psychedelics. By expanding its content library and marketing efforts, Delic can attract a larger audience and generate revenue through subscriptions and advertising. The market for online education is vast and growing, with increasing interest in alternative therapies and wellness practices. The timeline for growth is ongoing, with potential for significant expansion over the next 2-3 years. This can establish Delic as a leading provider of psychedelic education.
- Development of Intellectual Property: Delic's focus on research and development for cannabis and psychedelics presents a significant growth opportunity. By developing novel formulations and treatment protocols, the company can create valuable intellectual property that can be licensed or commercialized. The market for psychedelic-based pharmaceuticals is expected to grow rapidly in the coming years, driven by increasing regulatory acceptance and clinical research. The timeline for development is ongoing, with potential for significant breakthroughs over the next 3-5 years. This can establish Delic as a leading innovator in the psychedelic space.
- Strategic Partnerships and Acquisitions: Delic can pursue strategic partnerships and acquisitions to expand its reach and capabilities. By partnering with other companies in the psychedelic wellness space, such as research institutions or therapy providers, Delic can gain access to new technologies, markets, and expertise. The market for mergers and acquisitions in the psychedelic industry is expected to increase in the coming years, as companies seek to consolidate their positions. The timeline for partnerships and acquisitions is ongoing, with potential for significant deals over the next 1-2 years. This can accelerate Delic's growth and market leadership.
- Increased Public Awareness and Acceptance: As public awareness and acceptance of psychedelics increase, Delic is well-positioned to benefit from the growing demand for psychedelic therapies and education. The company's media platforms and educational resources can play a key role in shaping public perception and promoting responsible use of psychedelics. The timeline for increased awareness and acceptance is ongoing, with potential for significant progress over the next 3-5 years. This can create a more favorable regulatory environment and drive increased investment in the psychedelic industry.
Opportunities
- Expansion of ketamine infusion clinic network across North America.
- Growth of online education platform through content expansion and marketing efforts.
- Development of intellectual property for novel psychedelic therapies.
- Strategic partnerships and acquisitions to expand reach and capabilities.
Threats
- Unfavorable regulatory changes regarding psychedelic therapies.
- Increased competition from larger and more established players.
- Negative public perception or safety concerns regarding psychedelics.
- Economic downturn impacting consumer spending on wellness services.
Competitive Advantages
- Diversified business model across media, education, and clinical treatments reduces reliance on any single revenue stream.
- Established media platforms like Reality Sandwich provide a strong brand presence and audience reach.
- Ownership of ketamine infusion clinics offers a direct channel for delivering therapeutic treatments.
About DELCF
Delic Holdings Corp., headquartered in Vancouver, Canada, is a multifaceted company operating within the rapidly evolving psychedelic wellness industry. Founded with the vision of fostering a comprehensive ecosystem around psychedelic culture and therapeutic applications, Delic has established a diverse portfolio of assets. These include media platforms, educational resources, and clinical treatment centers. The company's media arm includes 'The Delic,' a platform for public discourse on psychedelic culture; 'Meet Delic,' an event organizer promoting safety, harm reduction, and mental health discussions; 'Reality Sandwich,' an online education platform with approximately 10,000 pieces of content; and 'Delic Radio,' a podcast exploring news, science, culture, and policy related to psychedelics. Delic also focuses on intellectual property development for cannabis and psychedelics through research and development initiatives. Furthermore, Delic operates two ketamine infusion treatment clinics and owns thirteen ketamine infusion treatment clinics, offering therapeutic interventions. This combination of media, education, and clinical services positions Delic as a notable player in the emerging psychedelic medicine market in the United States and Canada.
What They Do
- Operates 'The Delic', a creative platform for psychedelic culture discourse.
- Organizes 'Meet Delic' events to promote safety, harm reduction, and mental health discussions related to psychedelics.
- Manages 'Reality Sandwich', an online education platform with psychedelic guides, news, and culture content.
- Produces 'Delic Radio', a podcast discussing psychedelic-related topics with experts.
- Focuses on developing intellectual property for cannabis and psychedelics through research and development.
- Owns and operates two ketamine infusion treatment clinics.
- Owns thirteen ketamine infusion treatment clinics.
Business Model
- Generates revenue through ketamine infusion treatments at its clinics.
- Monetizes its media platforms through advertising, sponsorships, and event ticket sales.
- Explores revenue opportunities through licensing or commercialization of intellectual property developed through R&D.
Industry Context
Delic Holdings Corp. operates within the rapidly expanding psychedelic wellness industry, a sector gaining increasing attention for its potential therapeutic applications. The market is driven by growing awareness of mental health issues and the limitations of traditional treatments. While still in its early stages, the industry is attracting significant investment and research, with companies exploring the use of psychedelics for conditions such as depression, anxiety, and PTSD. Delic's diversified approach, combining media, education, and clinical services, positions it to capitalize on this evolving landscape. Competitors are emerging across various segments, from drug development to therapy clinics.
Key Customers
- Individuals seeking ketamine infusion treatments for mental health conditions.
- Individuals interested in learning about psychedelic culture and therapies.
- Professionals and researchers in the cannabis and psychedelic industries.
Financials
Chart & Info
Delic Holdings Corp. (DELCF) stock price: Price data unavailable
Latest News
No recent news available for DELCF.
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for DELCF.
Price Targets
Wall Street price target analysis for DELCF.
MoonshotScore
What does this score mean?
The MoonshotScore rates DELCF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Kevin Nicholson
CEO
Kevin Nicholson is the CEO of Delic Holdings Corp. His background includes experience in managing and scaling businesses within the emerging wellness sector. He has a track record of building and leading teams, developing strategic partnerships, and driving revenue growth. Nicholson's expertise lies in identifying market opportunities and executing innovative business strategies. He is focused on positioning Delic as a leader in the psychedelic wellness industry.
Track Record: Under Kevin Nicholson's leadership, Delic Holdings Corp. has expanded its media platforms, increased its clinic network, and advanced its research and development efforts. He has overseen the company's strategic acquisitions and partnerships, contributing to its growth and market presence. Nicholson has also focused on building a strong team and fostering a culture of innovation within the company.
DELCF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Delic Holdings Corp. may not meet the minimum financial standards required for higher tiers like OTCQB or OTCQX. Companies in this tier may have limited financial disclosure and may not be subject to the same regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries a higher degree of risk due to the potential for limited information and liquidity.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure increases the risk of investing in DELCF.
- Lower trading volume and wider bid-ask spreads can lead to price volatility.
- The OTC Other tier indicates a higher degree of risk compared to major exchanges.
- The regulatory oversight is less stringent for OTC-listed companies.
- Verify the company's financial statements and SEC filings (if any).
- Research the company's management team and their track record.
- Assess the company's business model and competitive landscape.
- Evaluate the company's growth potential and market opportunities.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before making any investment decisions.
- The company has established media platforms and ketamine infusion clinics.
- The company is focused on research and development for cannabis and psychedelics.
- The company has a management team with experience in the wellness sector.
DELCF Communication Services Stock FAQ
What does Delic Holdings Corp. do?
Delic Holdings Corp. operates in the psychedelic wellness space, providing various medicines and treatments in the United States and Canada. It operates media platforms like 'The Delic' and 'Reality Sandwich' to foster public discourse and education around psychedelics. Additionally, the company owns and operates ketamine infusion clinics, offering therapeutic treatments. Delic also focuses on developing intellectual property through research and development for cannabis and psychedelics, positioning itself as a multifaceted player in the emerging psychedelic medicine market.
What do analysts say about DELCF stock?
As of 2026-03-16, formal analyst ratings for DELCF are unavailable, likely due to its OTC listing and small market capitalization. Investors should conduct their own due diligence and consider the company's growth potential, financial risks, and the evolving regulatory landscape of the psychedelic wellness industry. Key valuation metrics to monitor include revenue growth, gross margin, and cash flow. The company's success will depend on its ability to execute its growth strategy and navigate the regulatory environment.
What are the main risks for DELCF?
The main risks for Delic Holdings Corp. include regulatory uncertainty surrounding psychedelic therapies, increased competition from larger players in the wellness industry, and potential negative public perception or safety concerns regarding psychedelics. The company's negative profit margin also poses a financial risk. As an OTC-listed company, DELCF faces liquidity risks and limited financial disclosure requirements, requiring investors to conduct thorough due diligence. These factors could impact the company's ability to achieve its growth objectives and generate shareholder value.
How does Delic Holdings Corp. compare to competitors in its industry?
Delic Holdings Corp. distinguishes itself through its diversified approach, integrating media platforms, educational resources, and clinical treatments within the psychedelic wellness sector. While some competitors may focus solely on drug development or therapy services, Delic aims to create a comprehensive ecosystem around psychedelic culture. However, Delic's smaller size and OTC listing may present challenges in competing with larger, more established companies with greater financial resources and brand recognition.
What are the key financial metrics investors watch for DELCF?
Given Delic Holdings Corp.'s position in the emerging psychedelic wellness sector, key financial metrics include revenue growth, gross margin, and cash burn rate. Revenue growth indicates the company's ability to attract customers and expand its market share. A high gross margin, currently at 100.0%, suggests efficient operations. Monitoring the cash burn rate is crucial, as the company's negative profit margin indicates it is currently spending more than it earns. Investors should also track the company's progress towards profitability and positive cash flow.
What are the key factors to evaluate for DELCF?
Delic Holdings Corp. (DELCF) currently holds an AI score of 57/100, indicating moderate score. Key strength: Diversified business model encompassing media, education, and clinical treatments.. Primary risk to monitor: Potential: Unfavorable regulatory changes regarding psychedelic therapies.. This is not financial advice.
How frequently does DELCF data refresh on this page?
DELCF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven DELCF's recent stock price performance?
Recent price movement in Delic Holdings Corp. (DELCF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Diversified business model encompassing media, education, and clinical treatments.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available for OTC-listed companies.
- Analyst ratings may not be available for DELCF due to its small market capitalization.